Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
Fractyl Health’s $110 Million Initial Public Offering
Vistagen’s US$100 Million Underwritten Offering
Latham & Watkins LLP represents Vistagen in the offering. Vistagen Therapeutics, Inc. (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for...
Mercer International Inc.’s US$200 Million Senior Notes Private Offering
Latham & Watkins advises on Mercer International offering. Mercer International Inc. (Nasdaq: MERC), a global forest products company with operations in Germany, the United States, and...
Immuneering’s $30 Million Common Shares Offering
Latham & Watkins represented Immuneering in the offering, while Sidley Austin represented the underwriters involved. Immuneering Corporation (Nasdaq: IMRX) announced the pricing of its underwritten offering...
CNH Industrial Capital’s $600 Million Notes Offering
Sullivan & Cromwell advised CNH Industrial Capital, and Latham & Watkins advised the underwriters. CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announced that its wholly...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Xponential Fitness’ Common Stock Offering
Davis Polk advised Xponential Fitness, while Latham & Watkins represented the underwriters in the offering. Xponential Fitness, Inc., the largest global franchisor of boutique fitness brands,...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...